Kenya Celebrates Breakthrough in Specialized Healthcare with First Kidney Transplants

The surgeries were supported through the Social Health Authority (SHA), reducing patients’ financial burden and enhancing access to specialized kidney care in line with the country’s Universal Health Coverage goals. In a major milestone for Kenya’s healthcare system, the Kenya University Teaching, Referral and Research Hospital (KUTRRH) has successfully conducted its first two kidney transplant…

Read More

“This support gives us hope”: A journey to motherhood in the midst of Tropical Cyclone Chido

Tropical Cyclone Chido is estimated to have killed 120 people and affected over 450,000. A lack of shelter, food shortages, and the need for long-term medical and psychosocial support are some of the key priorities for recovery SANDTON, South Africa, January 21, 2025/ — When Tropical Cyclone Chido tore through northern Mozambique in December 2024,…

Read More

Angola Celebrates 50 Years with New Hospital Opening

Luanda, Angola – 15th November 2024* – Angola marked a significant milestone in its 50th year of independence with the opening of the Cuanza Norte General Hospital, the third to be inaugurated within a year. The new facility, a key component of the country’s healthcare expansion, was officially opened by President João Gonçalves Lourenço in…

Read More

Nigeria: MSF Overwhelmed by Surge in Severely Malnourished Children Admissions

Médecins Sans Frontières (MSF) facilities in northern Nigeria are grappling with an unprecedented surge in admissions of severely malnourished children, far surpassing previous years’ figures. Driven by life-threatening complications, this surge has left medical facilities struggling to cope with double the number of admissions compared to last year in certain locations. Disturbingly, this influx is…

Read More

New York’s Outpatient Initiative for Alleviating Allergic Reactions to Cancer Therapies Sets a Record

Montefiore Einstein Comprehensive Cancer Center (MECCC) pioneers a groundbreaking outpatient therapy desensitization program, offering hope to cancer patients facing hypersensitivity reactions (HSRs) to vital treatments. Traditionally, patients experiencing HSRs endured grueling chemotherapy desensitization treatments in hospital ICUs. However, MECCC’s outpatient program has revolutionized care, completing 200 procedures and enabling patients to receive crucial therapies without…

Read More

Sensorum Health and Intermountain Health Forge Alliance to Enhance Health Outcomes for Older Adults with Chronic Conditions

Sensorum Health and Intermountain Health have partnered to revolutionize healthcare for older adults with chronic conditions. By combining remote monitoring technology and clinical expertise, they aim to improve health outcomes and primary care access. The focus is on early detection and proactive, personalized care at home to prevent hospitalizations and reduce healthcare costs.

Read More

Tampa General Hospital Honored as One of America’s Greatest Workplaces for Women by Newsweek

Tampa General Hospital has been recognized as one of “America’s Greatest Workplaces for Women” by Newsweek, highlighting its commitment to inclusivity and equity. With a focus on compensation and work-life balance, the hospital stands out among employers nationwide. It has a strong representation of women in leadership roles and provides diverse support initiatives for its workforce.

Read More

Visit Visalia to Celebrate Autism Month with a Commitment to Inclusion

Visalia, the nation’s first certified autism destination, gears up to celebrate Autism Awareness Month in April. Recent survey results show a willingness to travel if autism-certified facilities were available. Visalia, with its commitment to inclusion, offers a welcoming environment for neurodiverse travelers and is a pioneer in promoting acceptance and accessibility for people with autism.

Read More

U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients

– The full approval of ELAHERE is based on the confirmatory MIRASOL Phase 3 trial that supports the medicine as a potential new standard of care for folate receptor alpha (FRα)-positive, platinum-resistant ovarian cancer (PROC)

– Data show that ELAHERE treatment resulted in an overall survival benefit and reduced the risk of cancer progression by 35%

– ELAHERE represents AbbVie’s first approved solid tumor treatment following the recent acquisition of ImmunoGen

Read More